Загрузка...

Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

There are few data regarding disparities in overall survival (OS) between Asian and white men with metastatic castration-resistant prostate cancer (mCRPC). We compared OS of Asian and white mCRPC men treated in phase III clinical trials with docetaxel and prednisone (DP) or a DP-containing regimen....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JNCI Cancer Spectr
Главные авторы: Halabi, Susan, Dutta, Sandipan, Tangen, Catherine M, Rosenthal, Mark, Petrylak, Daniel P, Thompson, Ian M, Chi, Kim N, De Bono, Johann S, Araujo, John C, Logothetis, Christopher, Eisenberger, Mario A, Quinn, David I, Fizazi, Karim, Morris, Michael J, Higano, Celestia S, Tannock, Ian F, Small, Eric J, Kelly, William Kevin
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7190204/
https://ncbi.nlm.nih.gov/pubmed/32368717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa003
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!